RMD R&D Expenses

ResMed · R&D Expenses

RMD logo

RMD R&D Expenses

Latest reported$378.28M
RMD TTM R&D Expenses ($0.00 → $378.28M)
High-resolution chart · PNG

RMD r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

ResMed R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
378,284,000
359,002,000
348,679,000
339,083,000
331,284,000
325,702,000
318,832,000
311,339,000
307,525,000
304,808,000
304,170,000
300,164,000
287,642,000
273,816,000
264,181,000
256,814,000
253,576,000
249,133,000
238,273,000
230,701,000
225,284,000
217,929,000
213,437,000
208,445,000
201,945,000
200,563,000
196,724,000
189,892,000
180,650,000
169,169,000
158,993,000
156,525,000
155,149,000
152,198,000
149,894,000
147,441,000
144,472,000
142,146,000
135,125,000
125,905,000
118,651,000
112,794,000
111,709,000
112,033,000
114,865,000
118,138,000
120,644,000
120,887,000
118,226,000
117,820,000
119,479,000
120,268,000
120,125,000
116,646,000
113,855,000
110,747,000
109,733,000
108,798,000
103,720,000
98,474,000
92,007,000
84,981,000
79,940,000
77,027,000
75,202,000
72,219,000
67,822,000
63,678,000
63,057,000
63,679,000
64,800,000
64,804,000
60,524,000
57,099,000
55,155,000
52,264,000
50,106,000
47,003,000
43,087,000
39,647,000
37,217,000
34,269,000
32,366,000
32,120,000
30,514,000
28,429,000
28,047,000
26,971,000
26,169,000
26,376,000
24,586,000
22,156,000
20,534,000
18,439,000
17,163,000
15,944,000
14,910,000
14,005,000
13,230,000
12,118,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.